Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
13.78
-0.14 (-1.01%)
Aug 5, 2026, 3:50 PM EDT - Market open
Corvus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Current | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 1,159 | 1,230 | 575 | 550 | 298 | 217 | 363 | 330 | 114 | 87 | 86 | 72 | 112 | 42 | 40 | 38 | 46 | 76 | 112 | 225 | |
Market Cap Growth (YoY) | 266.47% | 467.51% | 58.33% | 66.58% | 161.81% | 148.35% | 320.89% | 361.51% | 1.67% | 105.98% | 118.11% | 87.78% | 142.96% | -44.49% | -64.73% | -83.08% | -59.31% | -35.30% | 11.08% | 100.22% |
Enterprise Value | 950.64 | 994.36 | 519.35 | 485.73 | 224.73 | 173.72 | 312.42 | 289.13 | 67.3 | 66.2 | 60.53 | 41.12 | 76.96 | 10.21 | -0.13 | -8.62 | -7.5 | 16.8 | 46.39 | 152.84 |
Last Close Price | 13.78 | 14.63 | 7.70 | 7.37 | 4.00 | 3.18 | 5.35 | 5.28 | 1.82 | 1.78 | 1.76 | 1.46 | 2.29 | 0.91 | 0.85 | 0.82 | 0.99 | 1.64 | 2.41 | 4.84 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 80.67 |
PB Ratio | 4.86 | 5.11 | 9.40 | 7.67 | 3.72 | 4.39 | 11.15 | 26.63 | 2.22 | 2.62 | 2.23 | 1.62 | 2.26 | 0.87 | 0.71 | 0.59 | 0.57 | 0.85 | 1.15 | 2.14 |
P/TBV Ratio | 4.78 | 5.47 | 10.44 | 8.51 | 3.88 | 4.85 | 11.23 | 28.38 | 2.12 | 2.62 | 2.23 | 1.61 | 2.20 | 0.87 | 0.71 | 0.59 | 0.57 | 0.85 | 1.16 | 2.02 |
EV/EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.26 | 0.25 | - | - | - |
EV/EBIT Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.26 | 0.25 | - | - | - |
EV/FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.32 | 0.27 | - | - | - |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 |
Net Debt / Equity Ratio | -0.98 | -0.98 | -0.91 | -0.90 | -0.91 | -0.87 | -1.56 | -3.33 | -0.91 | -0.63 | -0.67 | -0.69 | -0.71 | -0.66 | -0.71 | -0.72 | -0.67 | -0.66 | -0.68 | -0.69 |
Net Debt / EBITDA Ratio | 4.93 | 15.89 | 4.58 | 6.13 | 7.17 | 4.35 | 6.29 | 5.71 | 7.87 | 3.39 | 4.58 | 5.51 | 6.27 | 4.93 | 7.13 | 3.78 | 7.74 | 8.13 | 9.80 | 8.10 |
Net Debt / FCF Ratio | 6.71 | 22.54 | 6.06 | 6.76 | 12.45 | 5.19 | 6.01 | 6.53 | 8.49 | 4.09 | 4.99 | 5.61 | 6.71 | 3.95 | 5.26 | 6.50 | 8.75 | 9.27 | 9.59 | 8.60 |
Quick Ratio | 19.55 | 19.55 | 6.05 | 8.14 | 8.76 | 4.77 | 1.47 | 0.90 | 3.55 | 3.30 | 3.96 | 4.41 | 4.71 | 4.21 | 3.99 | 3.59 | 5.62 | 6.83 | 7.22 | 6.78 |
Current Ratio | 19.81 | 19.81 | 6.21 | 8.29 | 8.91 | 4.90 | 1.54 | 0.92 | 3.62 | 3.40 | 4.07 | 4.53 | 4.82 | 4.29 | 4.06 | 3.67 | 5.80 | 6.95 | 7.36 | 6.97 |
Return on Equity (ROE) | -9.44% | -9.44% | -26.28% | -24.13% | -12.17% | 36.75% | -34.00% | -141.86% | -8.46% | -13.87% | -14.04% | -11.01% | -10.01% | -11.36% | -12.81% | -17.47% | -9.46% | -9.01% | -10.91% | -14.47% |
Return on Assets (ROA) | -9.52% | -9.52% | -17.45% | -15.18% | -13.32% | -19.94% | -14.16% | -13.10% | -9.68% | -12.72% | -9.93% | -8.41% | -7.47% | -8.24% | -6.38% | -12.49% | -6.95% | -7.04% | -6.99% | -10.33% |
Return on Invested Capital (ROIC) | -106.48% | -106.48% | -87.29% | -70.11% | -66.11% | -60.99% | -48.16% | -39.83% | -30.88% | -29.65% | -25.24% | -22.05% | -20.00% | -21.23% | -17.44% | -34.73% | -18.40% | -18.64% | -16.93% | -39.37% |
Return on Capital Employed (ROCE) | -10.22% | -10.22% | -25.65% | -24.93% | -15.52% | -23.76% | -22.45% | -25.43% | -11.71% | -15.02% | -11.75% | -10.02% | -8.48% | -9.26% | -7.21% | -14.30% | -7.82% | -7.91% | -7.87% | -11.91% |
Earnings Yield | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.24% |
Buyback Yield / Dilution | -24.98% | -19.75% | -21.38% | -24.19% | -30.25% | -53.25% | -39.37% | -36.20% | -25.71% | -5.33% | -5.34% | -5.19% | -2.03% | -0.01% | -0.00% | -5.93% | -10.19% | -34.88% | -57.41% | -48.97% |
Total Shareholder Return | -24.98% | -19.75% | -21.38% | -24.19% | -30.25% | -53.25% | -39.37% | -36.20% | -25.71% | -5.33% | -5.34% | -5.19% | -2.03% | -0.01% | -0.00% | -5.93% | -10.19% | -34.88% | -57.41% | -48.97% |